The Cell & Gene Meeting on the Med is Europe’s leading advanced therapies conference, uniting ATMP decision‑makers for focused discussions on commercialization, regulatory strategy, manufacturing innovation, and sector financing. With expert‑led panels, dedicated partnering meetings, and presentations from organizations across the gene and cell therapy landscape, the event offers a high‑value forum for scientific and strategic engagement.

As a Silver Sponsor, Touchlight is proud to support this year’s meeting and the progress of the global advanced therapy community. We’ll be onsite to share how our enzymatically produced, next‑generation DNA provides faster, safer, and more scalable solutions for gene therapies, vaccines, mRNA platforms, and emerging modalities.

Interested in next‑generation DNA manufacturing? Request a meeting with a Touchlight expert today.

Touchlight Attendees